Rheumatoid Arthritis Register | British Society for Rheumatology

Overview

Tracking progress of patients with severe rheumatoid arthritis (RA) who are receiving biologic agents, to monitor safety and effectiveness over the long-term.

The society's RA register has been in operation for more than 20 years and is run by an expert team based in the Versus Arthritis Epidemiology Unit at the University of Manchester. The register monitors the safety and effectiveness of biologic treatments and captures information about adverse events.

Patients on the register are flagged with the NHS Information Centre, which notifies the register of anyone who develops cancer plus any deaths, with their cause.

Patients with similar disease activity on conventional disease-modifying anti-rheumatic drugs and recruited in a cohort since closed still provide comparison data. The register is on the NIHR CLRN portfolio database, so there is financial support for registering patients.

Now recruiting for:

Amgevita	Benepali	Cimzia
Enbrel	Erelzi	Flixabi
Hulio	Humira	Hyrimoz
Idacio	Imraldi	Inflectra
Jyseleca	Kevzara	Olumiant
Remsima	Remicade	Rinvoq
Rixathon	RoActemra	Ruxience
Yuflyma	Xeljanz

If you're an NHS clinician, health professional or research network staff with a recruitment query about a patient or the treatment cohorts in rheumatoid arthritis, please get in touch.

The British Society for Rheumatology and the University of Manchester are joint data controllers for the register

Study website Submit enquiry

Visit study website

View study

Submit an enquiry

Submit now

The NIHR Principal Investigator Scheme

The BSRBR-RA and UK JIA Biologics register has signed up to a new initiative aimed at supporting the next generation of research study investigators.

Learn more about the NIHR Associate Principal Investigator Scheme - a six-month practical work training opportunity for healthcare professionals.

Find out more